Biovision technologies INC:1106882 [17-059899]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700612P
- Awardee
-
Biovision Technologies, Inc. UEI L9E5DAWNZXL9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,860
Award facts
- Contract value 100% obligated
- $23,860.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Biovision Technologies, Inc., a small business, for $23,860.40 on September 7, 2017, with an ultimate completion date of October 8, 2017. Place of performance is Bethesda, Maryland. The order calls for precision scientific imaging equipment or related optical/microscopy instrumentation. Pricing is firm fixed price.
Quick answers
Who was awarded contract HHSN261201700612P?
HHSN261201700612P was awarded to Biovision Technologies, Inc. by National Cancer Institute (National Institutes of Health) on September 7, 2017.
How much is contract HHSN261201700612P worth?
The government has obligated $23,860 on HHSN261201700612P.
Was contract HHSN261201700612P competed?
The extent of competition for HHSN261201700612P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award